In celebrating the bicentenary of Gregor Mendel’s birth, we reflect on progress and future directions in the application of genetics and genomics to delivering a cure for sickle cell disease, a classic Mendelian disorder that affects 5 million people globally, most of whom are in Africa.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pauling, L., Itano, H. A., Singer, S. J. & Wells, I. C. Sickle cell anemia a molecular disease. Science 110, 543–548 (1949).
Sankaran, V. G. et al. A functional element necessary for fetal hemoglobin silencing. N. Engl. J. Med. 365, 807–814 (2011).
Mtatiro, S. N. et al. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania. Am. J. Hematol. 90, E1–E4 (2015).
Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S. & The US National Genomi Research Institute. A vision for the future of genomics research. Nature 422, 835–847 (2003).
Tishkoff, S. A. & Kidd, K. K. Implications of biogeography of human populations for ‘race’ and medicine. Nat. Genet. 36, S21–S27 (2004).
Consortium, H. A. et al. Research capacity. Enabling the genomic revolution in Africa. Science 344, 1346–1348 (2014).
Makani, J. & Luzzatto, L. Of mice and men: from hematopoiesis in mouse models to curative gene therapy for sickle cell disease. Cell 185, 1261–1265 (2022).
Ribeil, J. A. et al. Gene therapy in a patient with sickle cell disease. N. Engl. J. Med. 376, 848–855 (2017).
Esrick, E. B. et al. Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. N. Engl. J. Med. 384, 205–215 (2021).
Frangoul, H. et al. CRISPR–Cas9 gene editing for sickle cell disease and beta-thalassemia. N. Engl. J. Med. 384, 252–260 (2021).
Acknowledgements
We thank all those from whom we have learned genetics, all those who have made advances in gene therapy, and all of our patients with sickle cell disease.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Makani, J., Nkya, S., Collins, F. et al. From Mendel to a Mendelian disorder: towards a cure for sickle cell disease. Nat Rev Genet 23, 389–390 (2022). https://doi.org/10.1038/s41576-022-00498-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41576-022-00498-1
This article is cited by
-
Thoughts on a legacy
Nature Reviews Genetics (2022)